Puma Biotechnology, Inc.
Cash Flow Statement
| Line Item | Jun 2012 | Mar 2012 | Dec 2011 | Sep 2011 | Jun 2011 | Mar 2011 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-14.8M | $-11.8M | $-9.8M | $-347.4K | $-34.3K | $-3.9K |
| Depreciation & Amortization | $69.5K | $49.0K | — | $168 | $168 | — |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $264.0K | $198.0K | — | — | — | — |
| Net Cash from Operating Activities | $-8.8M | $-2.8M | $-1.6M | $-143.2K | $-36.0K | $-3.9K |
| Investing Activities | ||||||
| Capital Expenditures | $240.5K | $187.2K | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-397.0K | $-424.0K | — | — | — | — |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $56.7M | $168.7K | $39.4K | $3.9K |
| Net Change in Cash | $-9.2M | $-3.2M | — | — | — | — |
| Free Cash Flow | $-9.0M | $-3.0M | — | — | — | — |